Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 June 2021 | Story Legopheng Maphile | Photo Charl Devenish
Nthabiseng Kotsokoane in front of the Sasol Library on the Bloemfontein Campus of the University of the Free State. She is wearing a pink blouse with floral patterns and leaning with her left elbow against a ledge whilst looking into the camera.
Nthabiseng Kotsokoane is a renowned library professional whose passionate efforts to advance library and information services in Africa and beyond are widely acknowledged Photo: Charl Devenish

The University of the Free State is proud to announce the appointment of Nthabiseng Kotsokoane as chairperson of the International Federation of Library Associations and Institutions (IFLA) new Regional Council and member of the IFLA Governing Board 2021 – 2023.

IFLA is the leading international body representing the interests of library and information services and their users. It is the global voice of the library and information profession.

Nthabiseng Kotsokoane is currently the Assistant Director at the University of the Free State Library Information Services. She previously worked at Monash University for 10 years as a director of the library services. Ms Kotsokoane is a renowned library professional whose passionate efforts to advance library and information services in Africa and beyond are widely acknowledged. She has vast experience in serving at various committees regionally and internationally. She served as a member of the IFLA women information Libraries Special Interest Group. She was later elected by LIASA into the IFLA IT committee. She is the current IFLA Africa section Chair 2017-2021.

 

Serving the international library community

Nthabiseng is not only active in IFLA but on the African continent as well, she is the past chair for the African Library & Information Associations & Institutions (AfLIA) academic library section Chair and a member of the AfLIA Governing Board.

As IFLA’s Regional Chair her key role will be to in increase the presence of world regions in IFLA and IFLA’s presence around the world focusing on advocacy and building capacity. She will lead efforts to provide input on IFLA advocacy work and review success in developing the regional dimension of the IFLA Strategy, as well as work to promote IFLA membership and fundraising in the regions.

This will include coordination and development of Regional Division action plans, review Regional Division activities in the following regions Regional Council and Regional Divisions for Asia and Oceania, Europe, Latin America and the Caribbean, Middle East and North Africa, North America and Sub-Saharan Africa. With her passion of developing and mentoring new library professionals we are certain that this new role will be of benefit to the international library community.

News Archive

New research informs improved treatment of brain inflammation
2017-10-13

Description: Sebolai and Ogundeji Tags: Microbiologist, Dr Adepemi Ogundeji,  

Dr Adepemi Ogundeji, researcher in the Department of Microbial,
Biochemical and Food Biotechnology at the
University of the Free State,
and Dr Olihile Sebolai,
her study leader from the same department.
Photo: Charl Devenish



Microbiologist Dr Adepemi Ogundeji has uncovered a new use for an old medicine that can potentially save lives and money. Under the guidance of her study leader, Dr Olihile Sebolai, Dr Ogundeji set out to fight a fungal disease caused by Cryptococcus neoformans. Drs Ogundeji and Sebolai are from the University of the Free State Department of Microbial, Biochemical and Food Biotechnology. 

Dr Ogundeji is passionate about education. “My aim will always be to transfer knowledge and skills in the microbiology field,” she said. “Dr Ogundeji’s study is celebrated in that it found a new purpose for existing medicines. An advantage of repositioning old medicines is by-passing clinical trials, which sometimes take 20 years, and the safety of such medicines is already known,” Dr Sebolai, explained.

Cryptococcus infections are difficult to control and often lead to brain inflammation. In layman’s terms: “Your brain is on fire”. People with HIV/Aids are especially vulnerable, surviving only about three months without treatment. Such patients may present with a Cryptococcus-emergent psychosis, and some with an out-of-control inflammatory condition when initiated on ARVs. 

Dr Ogundeji found that the clinically recommended dosage of aspirin (anti-inflammatory medicine), and quetiapine (anti-psychotic medicine) is sufficient to control the infection. Her exceptional work was readily published in some of the foremost journals in her field, namely, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept